• Develop and maintain a competitive executive compensation program in order to attract and retain qualified executives and to provide incentives to management that reward pay for performance in attaining the Company’s goals and objectives. 2 • Review and approve a peer group of companies to be used for marketplace trend analysis and to assess the competitiveness of the Company’s total compensation opportunities for executive officers. • Review and approve corporate goals and objectives relevant to the Chief Executive Officer’s compensation; in conjunction with the evaluation conducted by the Board as described in the Company’s Corporate Governance Guidelines, evaluate the Chief Executive Officer’s performance in light of these goals and objectives; and determine and approve (or determine and approve, and recommend to the independent members of the Board for their determination and approval) the Chief Executive Officer’s compensation level based on this evaluation and comparable market data provided by the independent compensation consultant. • In determining the long-term incentive component of the Chief Executive Officer’s compensation, consider the Company’s performance and relative shareholder return, the value of similar incentive awards to chief executive officers at comparable companies, and the awards given to the Chief Executive Officer in the past. • Review and approve the compensation of other executive officers of the Company, including benefits and perquisites, taking into consideration the Company’s performance, comparable market data, the performance of each executive officer, and such other factors as may, in the Committee’s discretion, be appropriate. • In evaluating and making recommendations regarding, or determining and approving, executive compensation, the Committee shall consider the results of the most recent shareholder advisory vote on executive compensation (“Say on Pay Vote”) required by Section 14A of the Securities Exchange Act of 1934, as amended (the “Exchange Act”). • With respect to incentive compensation plans and equity-based plans: • Make recommendations to the Board with respect to the approval of incentive compensation plans for executive officers and all equity-based plans. • Review and approve equity-based grants and awards, including long-term incentive plan awards, to officers, senior managers, key employees, and other employees of the Company and its subsidiaries under the Company’s equity-based plans. • Review and approve the performance criteria, target awards, payout criteria and like items for the Company’s annual incentive and long-term incentive compensation plans. • Review and approve (a) attainment levels under the Company’s annual incentive plan; (b) payments to executive officers of the Company under the annual incentive plan; and (c) payments to officers, senior managers and employees of the Company under the Company’s long-term incentive compensation plans. • Administer the Company’s equity-based incentive compensation plans and other plans adopted by the Board that contemplate administration by the Committee. • Review and approve special bonuses and/or other awards to executive officers on a case-by- case basis for outstanding performance. • Review and approve the terms of all employment agreements, management continuity agreements and change in control agreements for elected officers. 3 Non-employee Director Compensation. • Review the compensation of non-employee directors and make recommendations to the Board regarding changes to existing compensation levels. • Perform administrative functions with respect to the compensation of non-employee directors, including interpreting existing policy. • Review and approve (or approve and recommend to the Board for its approval) equity-based grants and awards to non-employee directors under the Company’s equity-based plans.

THE SOLUTION: EVOLVED TPEs PERFORM FOR HEALTHCARE APPLICATIONS Recent thermoplastic elastomer advancements give manufacturers the ability to use specialized TPEs for healthcare to modernize processing and minimize secondary operations. Because of their stringent regulatory compliance, healthcaregrade TPEs can help to bypass certain layers of red tape in order to get products to market faster.

As with conventional colorants, OnColor Naturals can be customized and combined with special effects to increase design possibilities. See how our specially formulated colorants can help differentiate your brand

Article Medical Hose Manufacturer Boosts Productivity With Specialized Material Medical hose manufacturer boosts productivity With specialized material.

Article Medical Hose Manufacturer Boosts Productivity With Specialized Material Medical hose manufacturer boosts productivity With specialized material.

Article Medical Hose Manufacturer Boosts Productivity With Specialized Material Medical hose manufacturer boosts productivity With specialized material.

Article Medical Hose Manufacturer Boosts Productivity With Specialized Material Medical hose manufacturer boosts productivity With specialized material.

Special formulations for medical applications. See how our specially formulated colorants can help differentiate your brand

CLEVELAND, April 7, 2020 /PRNewswire/ -- PolyOne Corporation (NYSE: POL) a premier provider of specialized polymer materials, services and sust CLEVELAND, March 18, 2020 /PRNewswire/ -- PolyOne Corporation (NYSE: POL) a premier provider of specialized polymer materials, services and sol

CLEVELAND – PolyOne Corporation (NYSE: POL), a premier provider of specialized polymer materials, services and solutions, today announced that Bradley C. PolyOne Corporation, with 2013 revenues of $3.8 billion, is a premier provider of specialized polymer materials, services and solutions.